Sir Philip Hampton
|
Non-Executive Chairman
|
Sir Andrew Witty
|
Chief Executive Officer
|
Mr Simon Dingemans
|
Chief Financial Officer
|
Dr Moncef Slaoui
|
Chairman, Global Vaccines
|
Professor Sir Roy Anderson
|
Independent Non-Executive Director
|
Mr Vindi Banga
|
Senior Independent Non-Executive Director
|
Ms Stacey Cartwright
|
Independent Non-Executive Director
|
Ms Lynn Elsenhans
Dr Jesse Goodman
|
Independent Non-Executive Director
Independent Non-Executive Director
|
Ms Judy Lewent
|
Independent Non-Executive Director
|
Mr Urs Rohner
|
Independent Non-Executive Director
|
UK Media enquiries:
|
David Mawdsley
|
+44 (0) 20 8047 5502
|
(London)
|
Simon Steel
|
+44 (0) 20 8047 5502
|
(London)
|
|
US Media enquiries:
|
Sarah Alspach
|
+1 202 715 1048
|
(Washington, DC)
|
Sarah Spencer
|
+1 215 751 3335
|
(Philadelphia)
|
|
Jenni Ligday
|
+1 202 715 1049
|
(Washington, DC)
|
|
Analyst/Investor enquiries:
|
Ziba Shamsi
|
+44 (0) 20 8047 5543
|
(London)
|
Tom Curry
|
+ 1 215 751 5419
|
(Philadelphia)
|
|
Gary Davies
|
+44 (0) 20 8047 5503
|
(London)
|
|
James Dodwell
|
+44 (0) 20 8047 2406
|
(London)
|
|
Jeff McLaughlin
|
+1 215 751 7002
|
(Philadelphia)]
|
Cautionary statement regarding forward-looking statements
GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Such factors include, but are not limited to, those described under Item 3.D 'Risk factors' in the company's Annual Report on Form 20-F for 2014.
|
Registered in England & Wales:
No. 3888792
|
Registered Office:
980 Great West Road
Brentford, Middlesex
TW8 9GS
|